Flurbiprofenum [Inn-Latin] en es it fr

Flurbiprofenum [Inn-Latin] Brand names, Flurbiprofenum [Inn-Latin] Analogs

Flurbiprofenum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Flurbiprofenum [Inn-Latin] Chemical_Formula


Flurbiprofenum [Inn-Latin] RX_link


Flurbiprofenum [Inn-Latin] fda sheet

Flurbiprofenum_[Inn-Latin] FDA

Flurbiprofenum [Inn-Latin] msds (material safety sheet)

Flurbiprofenum_[Inn-Latin] MSDS

Flurbiprofenum [Inn-Latin] Synthesis Reference

No information avaliable

Flurbiprofenum [Inn-Latin] Molecular Weight

244.261 g/mol

Flurbiprofenum [Inn-Latin] Melting Point

110-111 oC

Flurbiprofenum [Inn-Latin] H2O Solubility

8 mg/L

Flurbiprofenum [Inn-Latin] State


Flurbiprofenum [Inn-Latin] LogP


Flurbiprofenum [Inn-Latin] Dosage Forms

Capsule (sustained-release); Liquid; Tablet

Flurbiprofenum [Inn-Latin] Indication

Flurbiprofen tablets are indicated for the acute or long-term treatment of the signs and symptoms of rheumatoid arthritis and osteorarthritis.

Flurbiprofenum [Inn-Latin] Pharmacology

Flurbiprofen, a nonsteroidal antiinflammatory drug (NSAID) of the propionic acid class, is used for the relief of pain and inflammation associated with rheumatoid arthritis and osteoarthritis and for the inhibition of intraoperative miosis. Flurbiprofen exhibits antiinflammatory, analgesic, and antipyretic activities.

Flurbiprofenum [Inn-Latin] Absorption

The mean oral bioavailability of flurbiprofen from tablets is 96% relative to an oral solution.

Flurbiprofenum [Inn-Latin] side effects and Toxicity

LD50=10 mg/kg (orally in dogs).

Flurbiprofenum [Inn-Latin] Patient Information

Flurbiprofenum [Inn-Latin] Organisms Affected

Humans and other mammals